Taivital Biopharmaceutical Co. LTD is a promising biotechnology company with a GMP plant facility committed to the manufacturing and development of the highest quality of antibodies for in vitro clinical diagnosis. Our innovative Linear Array Epitope (LAE) technology distinguishes us from all others in immunogen design. This new technique combines the use of receptor-mediated uptake and an efficient antigen presentation to allow the induction of immune responses to generate antibodies with high affinity and high specificity against any antigen (including self-antigen). State-of-the-art technology combined with years of experience in immunogen preparation and antibody purification assures that we deliver superior immunogens and antibodies at affordable prices. Additionally, we specialize in a new affinity purification technology that purifies antibodies and offer this service to customers who need a GMP plant facility to prepare IVD antibodies.